- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07308301
Examination of the Relationship Between Quality of Life and Caregiving Burden Among Caregivers of Pediatric Oncology Patients
EXAMİNATİON OF THE RELATİONSHİP BETWEEN QUALİTY OF LİFE AND CAREGİVİNG BURDEN AMONG CAREGİVERS OF PEDİATRİC OCOLOGY PATİENTS
Primary Aim
The primary aim of this study is to determine the quality of life and caregiving burden levels of caregivers of pediatric oncology patients and to examine the relationship between these two variables.
Secondary Aims
To evaluate the differences between caregivers' sociodemographic characteristics (age, gender, education level, marital status, income level, etc.) and their quality of life.
To examine the differences between caregivers' sociodemographic characteristics and their caregiving burden levels.
To determine whether caregivers' quality of life and caregiving burden differ according to the diagnosis and treatment characteristics of pediatric oncology patients (duration of diagnosis, type of treatment, frequency of hospitalization, etc.).
Significance of the Study
Childhood cancer is a process that deeply affects not only the patient but also the family, particularly the caregivers. Family members who provide care for children often face intense physical, psychological, social, and economic burdens. These challenges reduce caregivers' quality of life and increase their caregiving burden.
Identifying the relationship between the quality of life and caregiving burden among caregivers of pediatric oncology patients is highly important in planning support services for families during the care process and in strengthening family-centered care practices by healthcare professionals.
The findings of this study will contribute to the development of family-centered approaches in nursing care, the design of psychosocial support programs, and a better understanding of caregivers' needs.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Being a family member who provides care for a child aged 0-18 years diagnosed with cancer
- The child being in the active treatment phase (chemotherapy, radiotherapy, post-surgical follow-up, etc.)
- Being able to read and write in Turkish and having sufficient literacy to complete the research questionnaire
- Willingness to participate in the study
Exclusion Criteria:
- Not being the primary caregiver of the child (serving only as a short-term companion)
- Being unable to complete the questionnaire due to a psychiatric diagnosis or communication difficulties
- The child having a disability
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Primary caregivers eighteen and older of hospitalized pediatric cancer patients will be included.
The study includes individuals who provide care for pediatric oncology patients.
The research will involve primary caregivers aged 18 years or older who provide care for a child diagnosed with cancer and who are currently hospitalized in the Pediatric Hematology and Oncology Unit of Başakşehir Çam and Sakura City Hospital.
The study will examine caregivers' sociodemographic characteristics, quality of life, and caregiving burden levels.
|
This intervention consists of assessing the quality of life and caregiving burden of primary caregivers of children diagnosed with cancer using standardized questionnaires and scales.
It does not involve any medical procedures, treatments, or experimental applications.
The intervention includes only the administration of data collection tools to caregivers and is therefore distinct from treatment-based interventions used in other clinical studies.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Caregiver Quality of Life Index-Cancer (CQOLC)
Time Frame: From the enrollment phase until the end of the 12-week data collection period.
|
The scale consists of 25 items and four subscales: burden (10 items: 9, 11, 14, 15, 18, 19, 20, 21, 25, 31), disruptiveness (6 items: 1, 2, 3, 5, 13, 29), positive adaptation (6 items: 17, 24, 26, 30, 32, 33), and financial distress (3 items: 6, 7, 8). The scale is rated on a Likert-type scale ranging from 0 (almost never), 1 (not much), 2 (somewhat), 3 (quite a bit), to 4 (very much). Subscale scores of the CQOLC are calculated by summing the items within each subscale. The total CQOLC score is obtained by summing all 25 items. The total CQOLC score ranges from 0 to 100, with higher scores indicating lower quality of life. The overall internal consistency coefficient of the scale is .88, while the Cronbach's alpha values for the subscales of burden, disruptiveness, positive adaptation, and financial distress are reported as .83, .79, .73, and .77, respectively. |
From the enrollment phase until the end of the 12-week data collection period.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Caregiver Burden Scale
Time Frame: From the enrollment phase until the end of the 12-week data collection period.
|
The scale consists of 36 items rated on a 5-point Likert scale and includes four subscales.
The emotional burden subscale comprises 12 items, the sociocultural and economic burden subscale comprises 11 items, the mental burden subscale comprises 7 items, and the physical burden subscale comprises 6 items.
Participants completing the scale indicate their level of agreement with statements related to the caregiving burden experienced during the process of caring for their child using the following response options: "1 = Never, 2 = Rarely, 3 = Sometimes, 4 = Often, 5 = Always."
The minimum possible total score is 36 (36 items × 1 point), and the maximum possible total score is 180 (36 items × 5 points).
The caregiver burden level is determined by summing the responses to all items.
Accordingly, mean score ranges are interpreted as follows: mean scores of 1.00-2.00
indicate "no or low burden," 2.00-3.00
indicate "mild to moderate burden," 3.00-4.00-5.00
indicate "
|
From the enrollment phase until the end of the 12-week data collection period.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-KAEK-11
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Childhood Cancer
-
Dana-Farber Cancer InstituteRecruitingChildhood Cancer | Childhood Cancer SurvivorsUnited States
-
Australian & New Zealand Children's Haematology...Medical Research Future Fund; Minderoo Foundation; Children's Cancer Institute...RecruitingChildhood Cancer | Relapsed Cancer | Refractory Cancer | Childhood Leukemia | Childhood Solid Tumor | Childhood Brain TumorNew Zealand, Australia
-
Sydney Children's Hospitals NetworkGerman Cancer Research Center; Australian & New Zealand Children's Haematology... and other collaboratorsActive, not recruitingChildhood Cancer | Relapsed Cancer | Refractory Cancer | Childhood Leukemia | Childhood Solid Tumor | Childhood Brain TumorAustralia
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
University of Colorado, DenverCompletedCancer | Childhood CancerUnited States
-
Children's Cancer Group, ChinaShanghai Children's Medical Center; Shanghai Municipal Center for Disease Prevention...Recruiting
-
Emory UniversityNational Cancer Institute (NCI)Completed
-
Technical University of MunichHelmholtz Zentrum MünchenCompleted
-
University of Texas Southwestern Medical CenterWithdrawn
-
University of RochesterM.D. Anderson Cancer Center; University of Colorado, Denver; University of Pittsburgh and other collaboratorsCompleted
Clinical Trials on Assessment of caregiver quality of life and burden
-
University of WashingtonNational Cancer Institute (NCI)CompletedCaregiver | Stage IIIA Ovarian Cancer | Stage IIIB Ovarian Cancer | Stage IIIC Ovarian Cancer | Stage IV Ovarian CancerUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterCompletedCaregiver BurdenUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnDepression | Fatigue | Anxiety Disorder
-
City of Hope Medical CenterCompletedBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Ductal Breast Carcinoma in SituUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Burkitt Lymphoma | Secondary... and other conditionsUnited States
-
Wales Cancer Trials UnitUnknownTobacco Use Disorder | Lung Cancer
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedPsychosocial Effects of Cancer and Its Treatment | Health Status UnknownUnited States
-
Centre Hospitalier Universitaire DijonCompletedIdiopathic Pulmonary Fibrosis | Patient-caregiver DyadsFrance
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedMalignant Lung NeoplasmUnited States